Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
- Let’s talk about men’s health and wellbeing
- Taking a leaf out of Amul’s textbook to help rare
- New Fed chair faces critical test at Jackson Hole as inflation fears mount
- Casting call for “America’s Next Bikini Chef” brings fitness competition to Little Rock
- Chinese woman, 31, faces lifelong walking issues after water
- Florida Department of Health advances plan to drop four school vaccine mandates
- Kampo Medicine May Ease Age
- The quiet power of pets: Can pets really support a family’s mental health and wellbeing? | ABS
Browsing: Clinical
Connecting people with clinical trials is complicated – even if people identify a promising match, there’s a slew of potentially thorny factors, including geographic incompatibility, and financial and time considerations
Cemacabtagene ansegedleucel (cema-cel, formerly ALLO-501A) is being evaluated in the Phase II ALPHA3 trial in patients who respond to first-line chemoimmunotherapy but remain positive for minimal residual disease. At day 45, plasma circulating tumour DNA had decreased by a median of 97.7 per cent with cema-cel, versus a 26.6 per cent increase under observation. No…
Spain leads the EU in clinical trials, according to 2025 approval data that show that nearly 1,000 studies were greenlit in the country last year
The psychedelics space is “at the cusp” of hitting it big as clinical evidence and policy support mount
Saanroo today announced the publication of a new human clinical study evaluating Trpti, its bioavailable oleoylethanolamide (OEA) ingredient powered by LipiSperse technology. Published in the peer-reviewed journal Frontiers in Endocrinology (Impact Factor: 5.7), the study provides new insight into how Trpti supports nutrient sensing and the body’s natural incretin response, further strengthening the scientific foundation…
ADAR1 inhibitor researched in outer space holds promise for AML and myelofibrosis now — and possibly cancers like glioblastoma multiforme in the future
Earlier this year, the U.S. Department of Health and Human Services (HHS) stopped recommending that all children get an annual influenza vaccine. Instead, it made the shot a matter of “shared clinical decision-making”—something for parents and a doctor to weigh case by case—citing, among other reasons, a lack of randomized controlled trials proving the vaccine’s…
Legal challenge to King’s College London research study claimed it could harm participants but was rejected
Novel stable isotope study conducted at Texas A&M University found Postbiotic Cultured Protein’s anabolic response and amino acid bioavailability were comparable to whey protein isolate and equal to or better than pea protein isolate
The University of Rochester Medicine Clinical and Translational Science Institute (CTSI) received grants totaling more than $29 million from the National Institutes of Health (NIH) to support translational science and research that improves human health outcomes. For more than 20 years, CTSI has supported health research at URochester Medicine, bringing in over $157 million in…

